FOLH1 and prostate cancer: Advances in imaging with prostate-cancer-specific PET tracers such as [11C]Choline, [18F]DCFPyL, and [68Ga]Ga-PSMA-11 have resulted in improved sensitivity and specificity for detecting metastatic foci [3,4,5].